MSB 11.8% $1.57 mesoblast limited

Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval, page-114

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,993 Posts.
    lightbulb Created with Sketch. 1379
    Great new, ASX madness. Why would anyone choose to dump after such a announcement? They could have sold yesterday if they were satisfied with their gains.
    Next news from the FDA would be around the 23 of this month. Rejection, very unlikely as this is the third BLA , except with either 2 month or 6 month review process. If we were to receive a 2 month review, get set early as in some cases approval can be made in 6 weeks , that would be around the later half of August. By the latest the 10 of September. 6 months would in my view be better as MSB would have a bit more time on hand to address any minor matters that the FDA need rectified. This would not necessarily mean a January decision, any thing that the FDA considers would take more than 2 months would receive a 6 month review.

    Further market sensitive announcement due 1 week from news from FDA . Should be a good month.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.57
Change
-0.210(11.8%)
Mkt cap ! $1.838B
Open High Low Value Volume
$1.72 $1.74 $1.56 $11.14M 6.818M

Buyers (Bids)

No. Vol. Price($)
4 2753 $1.57
 

Sellers (Offers)

Price($) Vol. No.
$1.57 13529 12
View Market Depth
Last trade - 14.17pm 15/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.